Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Alicante (106)

2026

  1. Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

    Therapeutic Advances in Gastroenterology, Vol. 19

  2. CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry

    Hematological Oncology, Vol. 44, Núm. 1

  3. Comparison of routine clinical profiles of patients with imported P. falciparum malaria and co-infection with Plasmodium ovale wallikeri or Plasmodium ovale curtisi

    Acta Tropica, Vol. 274

  4. Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study

    Australasian Journal of Dermatology, Vol. 67, Núm. 1, pp. e40-e44

  5. Epidemiological, Clinical and Allergic Profile of Patients With Dyshidrotic Eczema (Acute and Recurrent Vesicular Dermatitis): Evaluation of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy (REIDAC)

    Contact Dermatitis

  6. Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera

    Blood Cancer Journal

  7. Interlaboratory cross validation of acute myeloid leukemia fusion genes and mutational targets detected by PCR: Performance of PETHEMA central laboratories

    Leukemia Research, Vol. 160

  8. Lumen-Apposing Stents With or Without Pigtail in Endosonography-Guided Biliary Drainage for Malignant Distal Biliary Obstruction

    Clinical Gastroenterology and Hepatology, Vol. 24, Núm. 3, pp. 678-687.e21

  9. Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU

    Revista Espanola de Cardiologia, Vol. 79, Núm. 1, pp. 68-79

  10. Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study

    Journal of Clinical Oncology

  11. Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study

    American Journal of Hematology

  12. Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry

    Cancer, Vol. 132, Núm. 8

  13. Recurrence factors in familial papillary thyroid carcinoma

    Minerva endocrinology, Vol. 51, Núm. 1, pp. 4-16

  14. Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023)

    Clinical Infectious Diseases, Vol. 82, Núm. 3, pp. e511-e520

  15. Use of long-acting therapies for the HIV treatment in the Spanish pediatric cohort (CoRISpe)

    Journal of Infection and Public Health, Vol. 19, Núm. 5

2025

  1. Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?

    Epidemiology and Infection, Vol. 153

  2. Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure

    European Heart Journal, Vol. 46, Núm. 48, pp. 5222-5233

  3. Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience

    Transplantation and Cellular Therapy, Vol. 31, Núm. 5, pp. 299.e1-299.e14

  4. Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn’s Disease: A Prospective Cohort Study

    Medicina (Lithuania), Vol. 61, Núm. 12

  5. Comparative safety of enoxaparin versus other low-molecular-weight heparins in cancer-associated venous thromboembolism: a real-world cohort study from RIETE

    Research and Practice in Thrombosis and Haemostasis, Vol. 9, Núm. 8